Ketamine FAQs

Q. How much does ketamine treatment cost?

A. $350 for the evaluation and each ketamine infusion.  Payment for each visit must be made at the time of service.  There is no other required deposit or minimum number of treatments.

 

Q. Is ketamine FDA-approved for depression?

A. No. Ketamine is FDA-approved for use as an anesthetic, but not for depression.  However, medications may be used “off-label” for other indications if appropriate.  A growing body of research supports the use of ketamine for depression.  Esketamine is a closely related medicine which was recently approved for treatment-resistant depression.  See here for more information on esketamine.

 

 

Q. Does insurance cover the cost of ketamine treatment?

A. We are “in network” with Blue Cross Blue Shield PPO and submit claims to them for evaluations. However, the ketamine infusion treatments themselves are not covered by insurance.

 

 

Q. How do I know if ketamine treatment may be appropriate for me?

A. Contact our office to arrange an appointment for an evaluation. All patients new to our office must have an evaluation before determining suitability of ketamine treatment.  Please call 630-687-1653 to schedule an evaluation for ketamine treatment.

 

 

Q. What do we know about ketamine’s effectiveness?

A. Ketamine has been evaluated for depression treatment in many clinical studies over the past 10-plus years.  To view the results of a recent randomized, controlled clinical trial, visit the American Journal of Psychiatry website.

Esketamine FAQs

Q. How much does esketamine (Spravato™) treatment cost?

A. The medication and the treatment sessions are separate costs. The total combined cost is several hundred dollars per session, but the amount you pay depends on your insurance coverage.  We are in network with BCBS PPO insurance and they have been covering the costs consistently, not including deductibles, coinsurance, and copays.  Please call us for further information.

 

 

Q. Is esketamine (Spravato™) FDA-approved for depression?

A. Yes, esketamine is FDA-approved for treatment-resistant depression.  See here for more detailed information on esketamine.

 

 

Q. How is esketamine (Spravato™) given?

A. It is self-administered intranasally in the office. The recommended course is twice a week for 4 weeks, then weekly for 4 weeks, then individually determined after that. See here for additional information on esketamine.

 

 

Q. How do I know if esketamine (Spravato™) treatment may be appropriate for me?

A. Contact our office to arrange an appointment for an evaluation. All patients new to our office must have an evaluation before determining suitability of esketamine treatment.  Please call 630-687-1653 to schedule an evaluation.  Treatment will be coordinated by Lott Behavioral Health.